Gene · 3416
Papers2,652
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,652
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shotgun Kinetic Target-Guided Synthesis Approach Enables the Discovery of Small-Molecule Inhibitors against Pathogenic Free-Living Amoeba Glucokinases. | ACS Infect Dis | 2023 | 37820055 | PubTator, text mining | PubMed |
| Genetics and Epigenetics in Obesity: What Do We Know so Far? | Curr Obes Rep | 2023 | 37819541 | PubTator, text mining | PubMed |
| Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer's disease and brain aging. | J Neuroinflammation | 2023 | 37817156 | PubTator, text mining | PubMed |
| Inhibition of insulin-degrading enzyme in human neurons promotes amyloid-β deposition. | Neuronal Signal | 2023 | 37808160 | PubTator, text mining | PubMed |
| Targeting immunometabolic pathways for combination therapy in Alzheimer's disease. | Alzheimers Dement (N Y) | 2023 | 37786483 | PubTator, text mining | PubMed |
| Prevention of Alzheimer's disease through diet: An exploratory review. | Metabol Open | 2023 | 37781687 | PubTator, text mining | PubMed |
| The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication. | J Virol | 2023 | 37768083 | PubTator, text mining | PubMed |
| A Lysine Residue at the C-Terminus of MHC Class I Ligands Correlates with Low C-Terminal Proteasomal Cleavage Probability. | Biomolecules | 2023 | 37759700 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Exosomes: A Novel Approach to Diabetes-Associated Cognitive Impairment. | J Inflamm Res | 2023 | 37753267 | PubTator, text mining | PubMed |
| Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases. | Exp Neurobiol | 2023 | 37749925 | PubTator, text mining | PubMed |
| Comparative Study of Safety and Efficacy of Angiotensin-Receptor Blockers and Anti Amyloid-ß Monoclonal Antibodies for the Treatment of Alzheimer's Disease: A Systematic Review. | Cureus | 2023 | 37746412 | PubTator, text mining | PubMed |
| Defining and identifying cell sub-crosstalk pairs for characterizing cell-cell communication patterns. | Sci Rep | 2023 | 37735248 | PubTator, text mining | PubMed |
| Astrocyte metabolism and signaling pathways in the CNS. | Front Neurosci | 2023 | 37732313 | PubTator, text mining | PubMed |
| Alzheimer's Disease: Novel Targets and Investigational Drugs for Disease Modification. | Drugs | 2023 | 37728864 | PubTator, text mining | PubMed |
| Proteomic alterations in the brain and blood-brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer's disease. | Fluids Barriers CNS | 2023 | 37705104 | PubTator, text mining | PubMed |
| Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells. | J Immunother Cancer | 2023 | 37678917 | PubTator, text mining | PubMed |
| Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects. | J Alzheimers Dis Rep | 2023 | 37662616 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson's Disease Pathogenesis. | Nutrients | 2023 | 37630775 | PubTator, text mining | PubMed |
| A Metalloproteinase Cocktail from the Venom of Protobothrops flavoviridis Cleaves Amyloid Beta Peptides at the α-Cleavage Site. | Toxins (Basel) | 2023 | 37624257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3416/papers?page=8